Allergan, Teva to pay $54M in San Francisco opioid lawsuit | AP News
Teva Rockets After Hiring Former Novo Nordisk Exec As CEO | Investor's Business Daily
Teva made smart decision to move to us: Allergan CEO
A Drug Company Wagers the U.S. Won't Dare Charge It With Crimes - The New York Times
Teva Pharmaceuticals - Lixoft
Teva reaches $4.25B deal to settle opioid lawsuits | The Hill
Teva to pay New York $500M for role in opioid crisis - POLITICO
Teva Pharmaceuticals Soars After Buffett's Berkshire Hathaway Discloses Stake
Teva sees return to growth after opioid settlement, shares jump | Reuters
Teva, Allergan settle roles in opioid crisis for $4.25B, $2.37B respectively - Top Class Actions
New York could get $524M under opioid settlements with Teva - ABC News
Teva Reports Fourth Quarter and Full Year 2021 Financial Results | Business Wire
Teva settles with Oklahoma for $85 million in opioid case | PBS News Weekend
Opioid maker Teva agrees to tentative $4.25 billion deal - The Washington Post
Teva Pharmaceutical's U.S. Unit Indicted on Price-Fixing Charges - WSJ
In The News: Teva, Superfeet, Red Wing - Footwear Insight
Kåre Schultz new CEO of Teva - Nordic Life Science – the leading Nordic life science news service
Jury finds Teva Pharmaceuticals fueled opioid epidemic in New York State
Teva CEO: Company Would Have Gone Bankrupt Without Layoffs - Business - Haaretz.com
Teva proposes settlement in US opioid lawsuits | Israel National News - Arutz Sheva
Teva shares plunge as competitors get nod for copycat flagship drug | The Times of Israel
Teva reaches $523 million deal to settle opioid lawsuit with New York | CNN Business
Teva Settles Arkansas Price-Fixing Case for $931K | Arkansas Business News | ArkansasBusiness.com
Teva Pharmaceuticals - News, Articles etc. - European Pharmaceutical Review
Teva shares surge after announcing global opioid settlement
Earnings Preview: It's a mixed bag for Teva Pharma in Q3 | AlphaStreet
